Pharmicell Co., Ltd. 005690.KS Stock
Pharmicell Co., Ltd. Price Chart
Pharmicell Co., Ltd. 005690.KS Financial and Trading Overview
| Pharmicell Co., Ltd. stock price | 5530 KRW |
| Previous Close | 8200 KRW |
| Open | 8210 KRW |
| Bid | 7830 KRW x 0 |
| Ask | 7840 KRW x 0 |
| Day's Range | 7820 - 8290 KRW |
| 52 Week Range | 7820 - 14900 KRW |
| Volume | 883.41K KRW |
| Avg. Volume | 350.72K KRW |
| Market Cap | 470.43B KRW |
| Beta (5Y Monthly) | -0.689373 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 17500 KRW |
005690.KS Valuation Measures
| Enterprise Value | 395.26B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 19.646496 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 16.507 |
| Enterprise Value/EBITDA | -63.909 |
Trading Information
Pharmicell Co., Ltd. Stock Price History
| Beta (5Y Monthly) | -0.689373 |
| 52-Week Change | -39.48% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 14900 KRW |
| 52 Week Low | 7820 KRW |
| 50-Day Moving Average | 9143 KRW |
| 200-Day Moving Average | 10037 KRW |
005690.KS Share Statistics
| Avg. Volume (3 month) | 350.72K KRW |
| Avg. Daily Volume (10-Days) | 204.82K KRW |
| Shares Outstanding | 60M |
| Float | 39.82M |
| Short Ratio | N/A |
| % Held by Insiders | 9.61% |
| % Held by Institutions | 12.99% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 10:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2013 |
| Most Recent Quarter (mrq) | June 30, 2014 |
| Next Fiscal Year End | December 31, 2014 |
Profitability
| Profit Margin | -111.84% |
| Operating Margin (ttm) | -38.80% |
| Gross Margin | 22.74% |
| EBITDA Margin | -25.82% |
Management Effectiveness
| Return on Assets (ttm) | -4.98% |
| Return on Equity (ttm) | -29.25% |
Income Statement
| Revenue (ttm) | 23.94B KRW |
| Revenue Per Share (ttm) | 548.73 KRW |
| Quarterly Revenue Growth (yoy) | -58.19% |
| Gross Profit (ttm) | 8.68B KRW |
| EBITDA | -6184715776 KRW |
| Net Income Avi to Common (ttm) | -26781831168 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.44B KRW |
| Total Cash Per Share (mrq) | 209.31 KRW |
| Total Debt (mrq) | 11.74B KRW |
| Total Debt/Equity (mrq) | 13.94 KRW |
| Current Ratio (mrq) | 1.337 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7547197952 KRW |
| Levered Free Cash Flow (ttm) | -5792238592 KRW |
Profile of Pharmicell Co., Ltd.
| Country | South Korea |
| State | N/A |
| City | Seoul |
| Address | Ssangbong Building |
| ZIP | N/A |
| Phone | 82 2 3496 0114 |
| Website | https://www.pharmicell.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Pharmicell Co., Ltd., a biopharmaceutical company, develops and sells stem cell drugs in South Korea and internationally. The company operates in Biopharmaceutical Business and Biochemical Business divisions. It offers Cellgram_AMI that is manufactured using autologous bone marrow-derived mesenchymal stem cell to enhance the ejection fraction in patients with acute myocardial infarction reperfused by coronary angioplasty. The company's products under development include Cellgram_LC, a liver disease drug; Cellgram_ED for treating impotence; and Cellgram_DC, a cancer drug, as well as Hearticellgram_AM, a cardiac disease drug. It also develops and produces intermediates of raw material medicines, such as nucleosides, mPEGs, HDP-tosylate, and vincelactam; and low dielectric constant material, eco-friendly flame retardant, polyol synthesis catalyst, PET catalyst, etc. In addition, the company operates Twelve, a stem cell bank; develops and sells stem cell culture media cosmetics. Pharmicell Co., Ltd. was founded in 2002 and is headquartered in Seoul, South Korea.
Q&A For Pharmicell Co., Ltd. Stock
What is a current 005690.KS stock price?
Pharmicell Co., Ltd. 005690.KS stock price today per share is 5530 KRW.
How to purchase Pharmicell Co., Ltd. stock?
You can buy 005690.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pharmicell Co., Ltd.?
The stock symbol or ticker of Pharmicell Co., Ltd. is 005690.KS.
Which industry does the Pharmicell Co., Ltd. company belong to?
The Pharmicell Co., Ltd. industry is Biotechnology.
How many shares does Pharmicell Co., Ltd. have in circulation?
The max supply of Pharmicell Co., Ltd. shares is 60M.
What is Pharmicell Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Pharmicell Co., Ltd. PE Ratio is now.
What was Pharmicell Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Pharmicell Co., Ltd. EPS is 0 KRW over the trailing 12 months.
Which sector does the Pharmicell Co., Ltd. company belong to?
The Pharmicell Co., Ltd. sector is Healthcare.